Chemours (CC) Misses Q4 EPS by 5c

Chemours (NYSE: CC) reported Q4 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.36 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Traws Pharma (TRAW) Tops Q2 EPS by 27c